SCHEMBL7952777

SCHEMBL7952777

COC(=O)c1c(C(F)(F)F)c(-c2cccnc2F)n2c1C=CCC2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.35
ABL1 P00519 2/20 0.33
TDP2 O95551 1/20 0.33
CYP1A2 P05177 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
CDC7 O00311 1/20 0.32
DBF4 Q9UBU7 1/20 0.32
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
BDKRB1 P46663 1/20 0.31
GSK3B P49841 1/20 0.31
SMO Q99835 1/20 0.31
HCRTR1 O43613 1/20 0.31
DHODH Q02127 1/20 0.31
HSP90AA1 P07900 1/20 0.30
HSP90B1 P14625 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7952188 0.89 IDO1 (0.35) IDO1TDP2DHODHHSP90AA1HSP90B1
SCHEMBL7962686 0.89 DHODH (0.32) TDP2SMOHCRTR1DHODH
SCHEMBL8325506 0.88 DHODH (0.36) IDO1ABL1SMODHODH
SCHEMBL7965052 0.87 DHODH (0.36) IDO1ABL1TDP2CDC7DBF4
SCHEMBL7961614 0.87 PLAU (0.34) DHODH
SCHEMBL7967474 0.86 HSP90AA1 (0.35) IDO1TDP2CDC7DBF4BDKRB1
SCHEMBL7967142 0.86 IDO1 (0.34) IDO1ABL1TDP2CYP1A2CDC7
SCHEMBL7967763 0.83 HCRTR1 (0.35) IDO1ABL1TDP2CYP1A2HTR2A
SCHEMBL7965769 0.81 CFTR (0.41) CYP1A2HTR2AHTR2CHTR2BALDH1A1
SCHEMBL8329745 0.79 DHODH (0.38) IDO1GSK3BDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207675-B1 FOR PROPHYLAXIS AND THERAPY OF DISEASES IN WHICH ARE INVOLVED VIRUSES OF THE HERPES FAMILY AND/OR CYTOKINES IN PARTICULAR TUMOR NERCOSIS FACTOR-ALPHA RHONE-POULENC RORER S.A. (FR) 2001-03-27 US disclosed